VOGLI GM 1 TAB
Rs 196 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
VOGLI GM 1 TAB
Vogli GM1 Tablets offer a combined therapeutic approach to managing symptoms of vestibular disorders and Meniere's disease. Each tablet contains 16 mg of Betahistine dihydrochloride and 40 mg of Ginkgo Biloba extract. Betahistine helps to improve blood flow in the inner ear, which alleviates symptoms such as dizziness, vertigo, and tinnitus by stabilizing inner ear pressure. Ginkgo Biloba enhances circulation and provides additional cognitive and circulatory support. The dual-action formula makes Vogli GM1 effective for comprehensive symptom management. The tablets are designed for easy ingestion and accurate dosing, making them a practical choice for daily use. Packaged in a 10-tablet supply, Vogli GM1 provides a reliable option for both short-term relief and ongoing management of vestibular symptoms, contributing to improved overall quality of life.
Product Highlights and Usage:
Active Ingredient: Contains Betahistine dihydrochloride 16 mg and Ginkgo Biloba extract 40 mg, combining two active components for enhanced symptom management. Dual Action: Combines the effects of Betahistine, which improves inner ear circulation and reduces dizziness and vertigo, with Ginkgo Biloba, known for its cognitive and circulatory benefits. Symptom Relief: Effective in managing symptoms related to vestibular disorders and Meniere's disease, including dizziness, vertigo, and tinnitus. Convenient Tablet Form: Easy-to-swallow tablets ensure precise dosing and convenience for daily use. 10-Tablet Pack: Comes in a pack of 10 tablets, suitable for both short-term and long-term management of symptoms.
How it works:
VOGLI GM1 TABLET is used to manage type 2 diabetes mellitus. It combines three medications: glimepiride, metformin, and voglibose. Glimepiride lowers blood glucose levels by enhancing insulin release from the pancreas. Metformin decreases glucose production in the liver and reduces glucose absorption in the stomach and intestines, while also improving the body's insulin response. Voglibose inhibits the alpha-glucosidase enzyme, which breaks down complex carbohydrates into simple sugars, thereby slowing the digestion and absorption of carbohydrates in the small intestine. Together, these effects help reduce blood glucose levels in individuals with type 2 diabetes mellitus.
Directions for use:
Take VOGLI GM1 TABLET as directed by your physician. Swallow the tablet with a glass of water; do not crush or chew it. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition.
Warning & Precaution:
PREGNANCY CONTRAINDICATED: VOGLI GM1 TABLET is not recommended during pregnancy due to potential harm to the fetus. Consult your doctor before use. BREASTFEEDING CONTRAINDICATED: VOGLI GM1 TABLET is not recommended for breastfeeding women, as it may pass into breast milk and harm the nursing child. Consult your doctor before use. DRIVING AND USING MACHINES USE WITH CAUTION: Avoid driving or operating machinery if you experience reduced alertness or impaired reactions due to hypoglycemia while taking VOGLI GM1 TABLET. ALCOHOL CONSULT YOUR DOCTOR: Refrain from consuming alcohol while taking VOGLI GM1 TABLET, as it may lower your blood sugar levels. Consult your doctor for guidance. KIDNEY CONSULT YOUR DOCTOR: VOGLI GM1 TABLET is not recommended for patients with severe renal failure. Use with caution in those with other kidney conditions. Consult your doctor before use. LIVER CONSULT YOUR DOCTOR: VOGLI GM1 TABLET is not recommended for patients with severe liver disease. Use with caution in individuals with other liver conditions. Consult your doctor before use. ALLERGY CONTRAINDICATED: Do not take VOGLI GM1 TABLET if you are allergic to glimepiride, metformin, voglibose, other sulfonylureas/sulphonamides, or any other ingredients of this medicine. LUNGS CONTRAINDICATED: VOGLI GM1 TABLET is not recommended for patients with lung issues such as acute or chronic respiratory failure. Consult your doctor before use. HEART DISEASE CONTRAINDICATED: VOGLI GM1 TABLET is not recommended for patients with heart problems, including acute or chronic cardiac failure or recent myocardial infarction. Consult your doctor before use. USE IN PEDIATRICS CONTRAINDICATED: VOGLI GM1 TABLET is not recommended for children and adolescents (under 18 years) due to insufficient safety and effectiveness data. Consult your doctor before use. USE IN GERIATRICS USE WITH CAUTION: VOGLI GM1 TABLET should be used cautiously in elderly patients (65 years and older). Consult your doctor before use.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$